February 21, 2018

Gary A. Heimberg

Gary Heimberg’s practice focuses on public policy and government affairs matters for pharmaceutical and consumer health care clients. He has substantive knowledge of the current legislative and policy issues facing the pharmaceutical industry, including in the areas of intellectual property, OTC medicines, vaccines, biodefense, and FDA reform. Mr. Heimberg has also facilitated the implementation of internal policies and procedures to adhere to federal compliance requirements.

Mr. Heimberg’s pharmaceutical industry experience spans all spheres, including in-house, trade association, government and private practice positions.

Articles in the National Law Review database by Gary A. Heimberg

LATEST LEGAL NEWS & ANALYSIS

TRENDING LEGAL ANALYSIS

Upcoming Legal Education Events

Tuesday, February 27, 2018
Wednesday, February 28, 2018
Wednesday, February 28, 2018
Sunday, March 4, 2018
Wednesday, March 14, 2018
Wednesday, April 11, 2018
Thursday, April 19, 2018
Wednesday, May 9, 2018